DrugMapper


Display Options: Drug type Therapeutic Area Route of administration Mechanism of Action Indication Status		Total: 10647


Small molecule Approved Unknown Unknown HIV Infections Structural capsid protein inhibitor


Small molecule Unknown Unknown Unknown Liver Diseases; Pulmonary Disease, Chronic Obstructive; Renal Insufficiency; Sleep Apnea, Obstructive; Sleep Initiation and Maintenance Disorders Orexin receptor antagonist


Small molecule Approved Unknown Unknown Epilepsies, Partial; Epilepsy; Epilepsy, Complex Partial; Fragile X Syndrome; Smoking Cessation; Spasms, Infantile; Stress Disorders, Post-Traumatic; Tuberous Sclerosis; Seizures; Status Epilepticus GABA-A receptor; anion channel positive allosteric modulator


Protein Approved Unknown Unknown Breast Neoplasms; Lymphoma; Neutropenia Unknown


Oligonucleotide Approved Unknown Unknown Amyloid Neuropathies, Familial Unknown


Small molecule Approved Unknown Unknown Heart Failure; Cardiomyopathy, Hypertrophic Unknown


Combination Approved Unknown Unknown Unknown Unknown


Antibody Approved Unknown Unknown Kidney Neoplasms; Esophageal Neoplasms; Hematologic Neoplasms; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Multiple Myeloma; Myelodysplastic Syndromes; Peritoneal Neoplasms; Adenocarcinoma, Follicular; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Colorectal Neoplasms; Dysgerminoma; Fallopian Tube Neoplasms; Genital Neoplasms, Female; Glioblastoma; Head and Neck Neoplasms; HIV Infections; Lung Neoplasms; Mesothelioma; Neoplasms, Germ Cell and Embryonal; Neuroendocrine Tumors; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Sarcoma; Seminoma; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Thyroid Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Melanoma; Neoplasms; Small Cell Lung Carcinoma; Urinary Bladder Neoplasms; Urogenital Neoplasms Cytotoxic T-lymphocyte protein 4 inhibitor

Antibody

Approved

Unknown

Kidney Neoplasms; Esophageal Neoplasms; Hematologic Neoplasms; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Multiple Myeloma; Myelodysplastic Syndromes; Peritoneal Neoplasms; Adenocarcinoma, Follicular; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Colorectal Neoplasms; Dysgerminoma; Fallopian Tube Neoplasms; Genital Neoplasms, Female; Glioblastoma; Head and Neck Neoplasms; HIV Infections; Lung Neoplasms; Mesothelioma; Neoplasms, Germ Cell and Embryonal; Neuroendocrine Tumors; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Sarcoma; Seminoma; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Thyroid Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Melanoma; Neoplasms; Small Cell Lung Carcinoma; Urinary Bladder Neoplasms; Urogenital Neoplasms

Cytotoxic T-lymphocyte protein 4 inhibitor


Small molecule Approved Unknown Unknown Dermatitis, Atopic; Psoriasis Aryl hydrocarbon receptor agonist


Small molecule Small molecule Unknown Unknown Leukemia, Myeloid, Acute; Myelodysplastic Syndromes Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor


Protein Approved Unknown Unknown Hemorrhage; Liver Failure; Shock, Septic; Hemoptysis; Liver Cirrhosis; Renal Insufficiency Unknown


Protein Approved Unknown Unknown Non-alcoholic Fatty Liver Disease; Diabetes Mellitus, Type 2; Obesity Gastric inhibitory polypeptide receptor agonist


Small molecule Approved Unknown Unknown Immune System Diseases; Kidney Diseases; Liver Diseases; Colitis, Ulcerative; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Lupus Nephritis; Arthritis, Psoriatic; Psoriasis Tyrosine-protein kinase TYK2 negative allosteric modulator


Small molecule Approved Unknown Unknown Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Graft vs Host Disease; Leukemia, Lymphocytic, Chronic, B-Cell; Colorectal Neoplasms; Hodgkin Disease; Leukemia; Leukemia, Myeloid, Acute; Lymphoma, Mantle-Cell; Myeloproliferative Disorders; Primary Myelofibrosis; Prostatic Neoplasms, Castration-Resistant; Severe Acute Respiratory Syndrome Tyrosine-protein kinase JAK2 inhibitor

Small molecule

Approved

Unknown

Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Graft vs Host Disease; Leukemia, Lymphocytic, Chronic, B-Cell; Colorectal Neoplasms; Hodgkin Disease; Leukemia; Leukemia, Myeloid, Acute; Lymphoma, Mantle-Cell; Myeloproliferative Disorders; Primary Myelofibrosis; Prostatic Neoplasms, Castration-Resistant; Severe Acute Respiratory Syndrome

Tyrosine-protein kinase JAK2 inhibitor


Unknown Approved Unknown Unknown Unknown Unknown


Small molecule Approved Unknown Unknown Kidney Diseases; Liver Diseases; Psoriasis; Dermatitis, Atopic Tyrosine-protein kinase JAK1 inhibitor


Small molecule Investigational Unknown Unknown Carcinoma, Non-Small-Cell Lung; Breast Neoplasms; Carcinoma, Hepatocellular; Neoplasms; Cholangiocarcinoma; Sarcoma Fibroblast growth factor receptor inhibitor


Small molecule Approved Unknown Unknown Anemia, Sickle Cell; Thalassemia; Anemia Unknown


Enzyme Approved Unknown Unknown Niemann-Pick Diseases Sphingomyelin hydrolytic enzyme


Oligonucleotide Approved Unknown Unknown Amyotrophic Lateral Sclerosis SOD1 mRNA inhibitor


Small molecule Approved Unknown Unknown Essential Hypertension; Diabetes Mellitus; Diabetes Mellitus, Type 2 Sodium/glucose cotransporter 2 inhibitor


Antibody Approved Unknown Unknown Arthritis, Rheumatoid; Arthritis, Psoriatic; Hidradenitis Suppurativa; Psoriasis; Spondylitis, Ankylosing Interleukin 17A inhibitor


Protein Approved Unknown Unknown Wounds and Injuries; Brain Concussion; Brain Injuries; Fragile X Syndrome; Rett Syndrome Unknown


Small molecule Approved Unknown Unknown Multiple Myeloma; Neoplasms; Breast Neoplasms; Pancreatic Neoplasms; Fibromatosis, Aggressive Unknown


Small molecule Approved Unknown Unknown Kidney Diseases; Liver Diseases; Hot Flashes Neurokinin 3 receptor antagonist


Small molecule Approved Unknown Unknown Mycoses Unknown


Small molecule Approved Unknown Unknown Depressive Disorder; Essential Tremor; Parkinson Disease; Depression, Postpartum; Depressive Disorder, Major Unknown


Small molecule Approved Unknown Unknown Cocaine-Related Disorders; Depressive Disorder Unknown


Small molecule Approved Unknown Unknown Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell Tyrosine-protein kinase BTK inhibitor


Small molecule Approved Unknown Unknown Unknown PI3-kinase p110-delta subunit inhibitor


Small molecule Approved Unknown Unknown Liver Diseases; Melanoma; Breast Neoplasms; Friedreich Ataxia Unknown


Small molecule Approved Unknown Unknown Blepharitis Unknown


Small molecule Approved Unknown Unknown Wounds and Injuries; Peripheral Vascular Diseases; Anemia Hypoxia-inducible factor prolyl hydroxylase inhibitor


Protein Approved Unknown Unknown Amyotrophic Lateral Sclerosis; Hemoglobinuria, Paroxysmal; Myasthenia Gravis; Severe Acute Respiratory Syndrome Complement C5 inhibitor


Small molecule Approved Unknown Unknown Glomerulonephritis; Glomerulonephritis, Membranous; Atypical Hemolytic Uremic Syndrome; Glomerulonephritis, IGA; Hemoglobinuria, Paroxysmal Complement factor B inhibitor